|
| 36863485 | Elevated iNOS and 3'-nitrotyrosine in Kaposi's Sarcoma tumors and mouse model. | Tumour Virus Res | 2023 |
| 37889078 | The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC. | Nucleic Acids Res | 2023 |
| 37609144 | Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection. | bioRxiv | 2023 |
| 37606370 | Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer. | mBio | 2023 |
| 37723305 | Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer. | Nat Cancer | 2023 |
| 36993171 | Leukemia core transcriptional circuitry is a sparsely interconnected hierarchy stabilized by incoherent feed-forward loops. | bioRxiv | 2023 |
| 37149684 | Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment. | Nat Commun | 2023 |
| 37377614 | Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer. | Cancer Res Commun | 2023 |
| 36975214 | The Natural Stilbenoid (-)-Hopeaphenol Inhibits HIV Transcription by Targeting Both PKC and NF-κB Signaling and Cyclin-Dependent Kinase 9. | Antimicrob Agents Chemother | 2023 |
| 37205503 | Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis. | bioRxiv | 2023 |
| 37140445 | An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression. | Cancer Discov | 2023 |
| 37095257 | The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses. | Oncogene | 2023 |
| 36999023 | Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge. | Front Immunol | 2023 |
| 37328686 | Correction: NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment. | Oncogene | 2023 |
| 36963401 | Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis. | Cancer Cell | 2023 |
| 37461649 | PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis. | bioRxiv | 2023 |
| 36749725 | Common activities and predictive gene signature identified for genetic hypomorphs of TP53. | Proc Natl Acad Sci U S A | 2023 |
| 36548516 | Syntaphilin Regulates Neutrophil Migration in Cancer. | Cancer Immunol Res | 2023 |
| 36778367 | Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells. | Res Sq | 2023 |
| 36911698 | Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression <i>in vivo</i>. | Front Immunol | 2023 |
| 36712010 | The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses. | Res Sq | 2023 |
| 36711814 | Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas. | bioRxiv | 2023 |
| 36707623 | Correction: NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment. | Oncogene | 2023 |
| 36824975 | Perinuclear damage from nuclear envelope deterioration elicits stress responses that contribute to <i>LMNA</i> cardiomyopathy. | bioRxiv | 2023 |
| 36892943 | Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesions. | J Clin Invest | 2023 |
| 34432273 | Functional Annotation of MicroRNAs Using Existing Resources. | Methods Mol Biol | 2022 |
| 35650435 | Stromal changes in the aged lung induce an emergence from melanoma dormancy. | Nature | 2022 |
| 35726891 | KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer. | Cancer Immunol Res | 2022 |
| 35726818 | Mechanisms regulating transitory suppressive activity of neutrophils in newborns: PMNs-MDSCs in newborns. | J Leukoc Biol | 2022 |
| 35723626 | IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma. | Cancer Discov | 2022 |
| 35421198 | The nuclear lamina binds the EBV genome during latency and regulates viral gene expression. | PLoS Pathog | 2022 |
| 35420632 | Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis. | J Exp Med | 2022 |
| 35851616 | ADAR1 downregulation by autophagy drives senescence independently of RNA editing by enhancing p16<sup>INK4a</sup> levels. | Nat Cell Biol | 2022 |
| 35552618 | Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer. | Cancer Discov | 2022 |
| 35354906 | NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment. | Oncogene | 2022 |
| 36028493 | DAXX-ATRX regulation of p53 chromatin binding and DNA damage response. | Nat Commun | 2022 |
| 36261012 | Circadian lncRNA ADIRF-AS1 binds PBAF and regulates renal clear cell tumorigenesis. | Cell Rep | 2022 |
| 36223343 | Mitochondrial fitness and cancer risk. | PLoS One | 2022 |
| 36385526 | Ferroptosis of tumour neutrophils causes immune suppression in cancer. | Nature | 2022 |
| 36344556 | The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer. | Sci Rep | 2022 |
| 36083892 | The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. | Sci Immunol | 2022 |
| 35188070 | Small extracellular vesicle-mediated <i>ITGB6</i> siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells. | Cancer Biol Ther | 2022 |
| 35039491 | The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity. | Nat Commun | 2022 |
| 35177476 | Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerability. | Proc Natl Acad Sci U S A | 2022 |
| 35022320 | BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma. | Clin Cancer Res | 2022 |
| 33414169 | Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth. | Cancer Res | 2021 |
| 33883224 | Defective Epstein-Barr Virus Genomes and Atypical Viral Gene Expression in B-Cell Lines Derived from Multiple Myeloma Patients. | J Virol | 2021 |
| 33795874 | m<sup>6</sup>A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype. | Nat Cell Biol | 2021 |
| 33741967 | Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway. | Nat Commun | 2021 |
| 33566112 | Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. | J Exp Med | 2021 |